Table 3 Participants with plasma Phe ≤120 μmol/L, ≤360 μmol/L, or ≤ 600 μmol/L
n | Plasma Phe threshold, n (%) | |||
|---|---|---|---|---|
≤120 μmol/L | ≤360 μmol/L | ≤600 μmol/L | ||
Overalla | 80 | 63 (78.7%) | 64 (80.0%) | 66 (82.5%) |
Extension study | ||||
Week 48 | 61 | 20 (32.8%) | 28 (45.9%) | 35 (57.4%) |
Week 96 | 49 | 17 (34.7%) | 22 (44.9%) | 30 (61.2%) |
Week 144 | 45 | 19 (42.4%) | 25 (55.6%) | 29 (64.4%) |
Week 192 | 39 | 13 (33.3%) | 17 (43.6%) | 23 (58.9%) |
Week 240 | 22 | 11 (50.0%) | 13 (59.1%) | 16 (72.7%) |
Week 264 | 19 | 5 (26.3%) | 6 (31.6%) | 8 (42.1%) |
Overall | 68 | 57 (83.8%) | 58 (85.2%) | 59 (86.7%) |